Nitric oxide released from luminal s-nitroso-n-acetylcysteine increases gastric mucosal blood flow

Nitric oxide (NO)-mediated vasodilation plays a key role in gastric mucosal defense, and NO-donor drugs may protect against diseases associated with gastric mucosal blood flow (GMBF) deficiencies. In this study, we used the ex vivo gastric chamber method and Laser Doppler Flowmetry to characterize the effects of luminal aqueous NO-donor drug S-nitroso-N-acetylcysteine (SNAC) solution administration compared to aqueous NaNO2 and NaNO3 solutions (pH 7.4) on GMBF in Sprague-Dawley rats. SNAC solutions (600 μM and 12 mM) led to a rapid threefold increase in GMBF, which was maintained during the incubation of the solutions with the gastric mucosa, while NaNO2 or NaNO3 solutions (12 mM) did not affect GMBF. SNAC solutions (600 μM and 12 mM) spontaneously released NO at 37 °C at a constant rate of 0.3 or 14 nmol·mL-1·min-1, respectively, while NaNO2 (12 mM) released NO at a rate of 0.06 nmol·mL-1·min-1 and NaNO3 (12 mM) did not release NO. These results suggest that the SNAC-induced GMBF increase is due to their higher rates of spontaneous NO release compared to equimolar NaNO2 solutions. Taken together, our data indicate that oral SNAC administration is a potential approach for gastric acid-peptic disorder prevention and treatment.Nitric oxide (NO)-mediated vasodilation plays a key role in gastric mucosal defense, and NO-donor drugs may protect against diseases associated with gastric mucosal blood flow (GMBF) deficiencies. In this study, we used the ex vivo gastric chamber method and Laser Doppler Flowmetry to characterize the effects of luminal aqueous NO-donor drug S-nitroso-N-acetylcysteine (SNAC) solution administration compared to aqueous NaNO2 and NaNO3 solutions (pH 7.4) on GMBF in Sprague-Dawley rats. SNAC solutions (600 μM and 12 mM) led to a rapid threefold increase in GMBF, which was maintained during the incubation of the solutions with the gastric mucosa, while NaNO2 or NaNO3 solutions (12 mM) did not affect GMBF. SNAC solutions (600 μM and 12 mM) spontaneously released NO at 37 °C at a constant rate of 0.3 or 14 nmol·mL-1·min-1, respectively, while NaNO2 (12 mM) released NO at a rate of 0.06 nmol·mL-1·min-1 and NaNO3 (12 mM) did not release NO. These results suggest that the SNAC-induced GMBF increase is due to their higher rates of spontaneous NO release compared to equimolar NaNO2 solutions. Taken together, our data indicate that oral SNAC administration is a potential approach for gastric acid-peptic disorder prevention and treatment2034109412

Enhanced Photochemical Nitric Oxide Release From A Flutamide Derivative Incorporated In Pluronic F127 Micelles

The incorporation of nitric oxide (NO) photodonors into nontoxic vehicles may allow for the tunable control of topical NO release to treat pathological conditions associated with the impairment of NO production in the dermal vasculature. Pluronic F127 is a PEO-PPO-PEO triblock copolymer that is used as a nontoxic vehicle that undergoes thermally reversible micellization and gelation. In this study, we synthesized a thermally stable flutamide derivative, N-(3-aminopropyl)-3-(trifluoromethyl)-4-nitrobenzenamine (ATN), which is capable of releasing NO upon irradiation with visible light, as shown by real-time chemiluminescence NO detection. We demonstrated that the incorporation of ATN into the hydrophobic nuclei of F127 micelles leads to an enhancement of its photochemical NO release, which is consistent with the photodecomposition route associated with the nitro-to-nitrite photorearrangement of ATN. This mechanism underscores a new role of the F127 micelles as concentrating "nanoreactors" for hydrophobic NO releasing drugs. In this case, this effect may represent a new strategy for enhancing photochemical NO release from ATN, which makes the micellar F127/ATN solutions promising for topical NO application. © 2014 Elsevier B.V.2936571Nicolas, J., Mura, S., Brambilla, D., MacKiewicz, N., Couvreur, P., Design functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery (2014) Chem. Soc. Rev., 42, p. 1147Basak, R., Bandyopadhyay, R., Encapsulation of hydrophobic drugs in pluronic F127 micelles: Effects of drug hydrophobicity, solution temperature, and pH (2013) Langmuir, 29, p. 4350Alexander, S., Cosgrove, T., Prescott, S.W., Castle, T.C., Flurbiprofen encapsulation using pluronic triblock copolymers (2011) Langmuir, 27, p. 8054Miyazaki, S., Tobiyama, T., Takada, M., Attwood, D., Percutaneous absorption of indomethacin from pluronic F127 gels in rats (1995) J. Pharm. Pharmacol., 47, p. 455Foster, B., Cosgrove, T., Hammouda, B., Pluronic triblock copolymer systems and their interactions with ibuprofen (2009) Langmuir, 25, p. 6760Attwood, D., Collett, J.H., Tait, C.J., The micellar properties of the poly(oxyethylene)-poly(oxypropylene) copolymer Pluronic F127 in water and electrolyte solution (1985) Int. J. Pharm., 26, p. 25Alexandridis, P., Hatton, T.A., Poly(ethylene oxide)-poly(propylene oxide)-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: Thermodynamics, structure, dynamics, and modeling (1995) Colloids Surf. A: Physicochem. Eng. Asp., 96, p. 1Wanka, G., Hoffmann, H., Ulbricht, W., Phase-diagrams and aggregation behavior of poly(oxyethylene)- poly(oxypropylene)-poly(oxyethylene) triblock copolymers in aqueous-solutions (1994) Macromolecules, 27, p. 4145Dumortier, G., Grossiord, J.L., Agnely, F., Chaumeil, J.C., A review of poloxamer 407 pharmaceutical and pharmacological characteristics (2006) Pharm. Res., 23, p. 2709Escobar-Chávez, J.J., López-Cervantes, M., Naïk, A., Kalia, Y.N., Quintanar-Guerreo, D., Ganem-Quintanar, A., Applications of thermoreversible Pluronic F-127 gels in pharmaceutical formulations (2006) J. Pharm. Pharmaceut. Sci., 9, p. 339Carpenter, A.W., Schoenfisch, M.H., Nitric oxide release: Part II. Therapeutic applications (2012) Chem. Soc. Rev., 41, p. 3742Seabra, A.B., Durán, N., Nitric oxide-releasing vehicles for biomedical applications (2010) J. Mater. Chem., 20, p. 1624Georgii, J.L., Amadeu, T.P., Seabra, A.B., De Oliveira, M.G., Topical S-nitrosoglutathione-releasing hydrogel improves healing of rat ischaemic wounds (2011) J. Tissue Eng. Regen. Med., 5, p. 612Seabra, A.B., Fitzpatrick, A., Paul, J., De Oliveira, M.G., Weller, R.A., Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin (2004) Br. J. Dermatol., 151, p. 977Seabra, A.B., Martins, D., Simões, M.M.S.G., Da Silva, R., Brocchi, M., De Oliveira, M.G., Antibacterial nitric oxide-releasing polyester for the coating of blood-contacting artificial materials (2010) Artif. Organs, 34, p. 204Riccio, D.A., Schoenfisch, M.H., Nitric Oxide release: Part I. Macromolecular scaffolds (2012) Chem. Soc. Rev., 41, p. 3731Etchenique, R., Furman, M., Olabe, J.A., Photodelivery of nitric oxide from a nitrosothiol-derivatized surface (2000) J. Am. Chem. Soc., 122, p. 3967Shishido, S.M., Seabra, A.B., Loh, W., Ganzarolli De Oliveira, M., Thermal and photochemical nitric oxide release from S-nitrosothiols incorpored in Pluronic F127 gel: Potential uses for local and controlled nitric oxide release (2003) Biomaterials, 24, p. 3543Riccio, D.A., Coneski, P.N., Nichols, S.P., Broadnax, A.D., Schoenfisch, M.H., Photoinitiated nitric oxide-releasing tertiaty S-nitrosothiols-modified xerogels (2012) ACS Appl. Mater. Interfaces, 4, p. 796Georgii, J.L., Amadeu, T.P., Seabra, A.B., De Oliveira, M.G., Monte-Alto-Costa, A., Topical S-nitrosoglutathione-releasing hydrogel improves healing of rat ischaemic wounds (2001) J. Tissue Eng. Regen. Med., 5, p. 612Sortino, S., Nanostructured molecular films and nanoparticles with photoactivable functionalities (2008) Photochem. Photobiol. Sci., 7, p. 911Sortino, S., Photoactivated nanomaterials for biomedical release applications (2012) J. Mater. Chem., 22, p. 301Swaminathan, S., Garcia-Amorós, J., Fraix, A., Kandoth, N., Sortino, S., Raymo, F.M., Photoresponsive polymer nanocarriers with multifunctional cargo (2014) Chem. Soc. Rev.Kandoth, N., Mosinger, J., Gref, R., Sortino, S., A NO photoreleasing supramolecular hydrogel with bactericidal action (2013) J. Mater. Chem. B, 1, p. 3458Taladriz-Blanco, P., Pérez-Juste, J., Kandoth, N., Herves, P., Sortino, S., Layer-by-layer assembled gold nanoparticles with a tunable payload of a nitric oxide photocage (2013) J. Colloid Interface Sci., 407, p. 524Callari, F.L., Sortino, S., Amplified nitric oxide photorelease in DNA proximity (2008) Chem. Commun., p. 1971Schmolka, I.R., Astificial Skin, I., Preparation and properties of pluronic F-127 gels for treatment of burns (1972) J. Biomed. Mater. Res., 6, p. 571Coneski, P.N., Schoenfisch, M.H., Nitric oxide release: Part III. Measurement and reporting (2012) Chem. Soc. Rev., 41, p. 3753Marcilli, R.H.M., De Oliveira, M.G., Nitric oxide-releasing poly(vinyl alcohol) film for increasing dermal vasodilation (2014) Colloids Surf. B: Biointerfaces, 116, p. 643Sortino, S., Giuffrida, G.D.Q., Chilemi, R., Petralia, S., Marconi, G., Condorelli, G., Sciuto, S., The photochemistry of flutamide and its inclusion complex with b-cyclodextrin. Dramatic effect of the microenvironment on the nature and on the efficiency of the photodegradation pathways (2001) Photochem. Photobiol., 73, p. 5Sortino, S., Marconi, G., Condorelli, G., New insight on the photoreactivity of the phototoxic anti-cancer flutamide: Photochemical pathways selectively locked and unlocked by structural changes upon drug compartmentalization in phospholipid bilayer vesicles (2001) Chem. Commun., p. 1226Udagawa, C., Fukuyoshi, S., Morimoto, S., Tanimoto, Y., Nakagaki, R., Photochemistry of flutamide in various media: Investigation of the reaction mechanism as revealed by external magnetic field effects on product yields (2011) J. Photochem. Photobiol. A, 226, p. 5

Nitric Oxide Released From Luminal S-nitroso-n-acetylcysteine Increases Gastric Mucosal Blood Flow.

Nitric oxide (NO)-mediated vasodilation plays a key role in gastric mucosal defense, and NO-donor drugs may protect against diseases associated with gastric mucosal blood flow (GMBF) deficiencies. In this study, we used the ex vivo gastric chamber method and Laser Doppler Flowmetry to characterize the effects of luminal aqueous NO-donor drug S-nitroso-N-acetylcysteine (SNAC) solution administration compared to aqueous NaNO2 and NaNO3 solutions (pH 7.4) on GMBF in Sprague-Dawley rats. SNAC solutions (600 μM and 12 mM) led to a rapid threefold increase in GMBF, which was maintained during the incubation of the solutions with the gastric mucosa, while NaNO2 or NaNO3 solutions (12 mM) did not affect GMBF. SNAC solutions (600 μM and 12 mM) spontaneously released NO at 37 °C at a constant rate of 0.3 or 14 nmol·mL-1·min-1, respectively, while NaNO2 (12 mM) released NO at a rate of 0.06 nmol·mL-1·min-1 and NaNO3 (12 mM) did not release NO. These results suggest that the SNAC-induced GMBF increase is due to their higher rates of spontaneous NO release compared to equimolar NaNO2 solutions. Taken together, our data indicate that oral SNAC administration is a potential approach for gastric acid-peptic disorder prevention and treatment

Near-IR mediated intracellular uncaging of NO from cell targeted hollow gold nanoparticles

We demonstrate modulation of nitric oxide release in solution and in human prostate cancer cells from a thiol functionalized cupferron (TCF) absorbed on hollow gold nanoshells (HGNs) using near-infrared (NIR) light. NO release from the TCF-HGN conjugates occurs through localized surface heating due to NIR excitation of the surface plasmon. Specific HGN targeting is achieved through cell surface directed peptides, and excitation with tissue penetrating NIR light provides unprecedented spatio-temporal control of NO delivery to biological targets

Quantitative trait locus analysis of wheat quality traits

Milling and baking quality traits in wheat (Triticum aestivum L.) were studied by QTL analysis in the ITMI population, a set of 114 recombinant inbred lines (RILs) generated from a synthetic-hexaploid (W7985) x bread-wheat (Opata 85) cross. Grain from RILs grown in U.S., French, and Mexican wheat-growing regions was assayed for kernel-texture traits, protein concentration and quality, and dough strength and mixing traits. Only kernel-texture traits showed similar genetic control in all environments, with Opata ha alleles at the hardness locus Ha on chromosome arm 5DS increasing grain hardness, alkaline water retention capacity, and flour yield. Dough strength was most strongly influenced by Opata alleles at 5DS loci near or identical to Ha. Grain protein concentration was associated not with high-molecular-weight glutenin loci but most consistently with the Gli-D2 gliadin locus on chromosome arm 6DS. In Mexican-grown material, a 2DS locus near photoperiod-sensitivity gene Ppd1 accounted for 25% of variation in protein, with the ppd1-coupled allele associated with higher (1.1%) protein concentration. Mixogram traits showed most influence from chromosomal regions containing gliadin or low-molecular-weight glutenin loci on chromosome arms 1AS, 1BS, and 6DS, with the synthetic hexaploid contributing favorable alleles. Some RI lines showed quality values consistently superior to those of the parental material, suggesting the potential of further evaluating new combinations of alleles from diploid and tetraploid relatives, especially alleles of known storage proteins, for improvement of quality traits in wheat cultivars